168 related articles for article (PubMed ID: 1535445)
1. Locomotor-activating effects of the D2 agonist bromocriptine show environment-specific sensitization following repeated injections.
Hoffman DC; Wise RA
Psychopharmacology (Berl); 1992; 107(2-3):277-84. PubMed ID: 1535445
[TBL] [Abstract][Full Text] [Related]
2. Lack of cross-sensitization between the locomotor-activating effects of bromocriptine and those of cocaine or heroin.
Hoffman DC; Wise RA
Psychopharmacology (Berl); 1993; 110(4):402-8. PubMed ID: 7870909
[TBL] [Abstract][Full Text] [Related]
3. Attenuation of the locomotor-sensitizing effects of the D2 dopamine agonist bromocriptine by either the D1 antagonist SCH 23390 or the D2 antagonist raclopride.
Wise RA; Carlezon WA
Synapse; 1994 Jul; 17(3):155-9. PubMed ID: 7974197
[TBL] [Abstract][Full Text] [Related]
4. Prior experience with bromocriptine in the home cage attenuates locomotor sensitization in rats.
Kelsey JE; Carlezon WA
Behav Brain Res; 2002 Aug; 134(1-2):1-8. PubMed ID: 12191786
[TBL] [Abstract][Full Text] [Related]
5. Cross-sensitization between the motor activating effects of bromocriptine and caffeine: role of adenosine A(2A) receptors.
Fenu S; Cauli O; Morelli M
Behav Brain Res; 2000 Sep; 114(1-2):97-105. PubMed ID: 10996051
[TBL] [Abstract][Full Text] [Related]
6. Bromocriptine induces marked locomotor stimulation in dopamine-depleted mice when D-1 dopamine receptors are stimulated with SKF38393.
Jackson DM; Hashizume M
Psychopharmacology (Berl); 1986; 90(1):147-9. PubMed ID: 3094056
[TBL] [Abstract][Full Text] [Related]
7. [Effects of repeated administration of bromocriptine on ambulatory activity in mice, and changes in methamphetamine sensitivity in bromocriptine-experienced mice].
Asami T; Kuribara H; Tadokoro S
Yakubutsu Seishin Kodo; 1986 Sep; 6(3):309-17. PubMed ID: 3811623
[TBL] [Abstract][Full Text] [Related]
8. Repeated stimulation of D-1 dopamine receptors increases the circling response to bromocriptine in rats with a 6-OHDA lesion.
Rouillard C; Bédard P; Falardeau P; Di Paolo T
Eur J Pharmacol; 1988 Nov; 157(2-3):125-33. PubMed ID: 2975996
[TBL] [Abstract][Full Text] [Related]
9. Low dose apomorphine induces context-specific sensitization of hypolocomotion without conditioning: support for a new state dependent retrieval hypothesis of drug conditioning and sensitization.
Braga PQ; Dias FR; Carey RJ; Carrera MP
Pharmacol Biochem Behav; 2009 Aug; 93(2):128-33. PubMed ID: 19414026
[TBL] [Abstract][Full Text] [Related]
10. Antagonism of bromocriptine-induced cage climbing behaviour in mice by the selective D-2 dopamine receptor antagonists, metoclopramide and molindone.
Balsara JJ; Nandal NV; Gada VP; Bapat TR; Chandorkar AG
Indian J Physiol Pharmacol; 1986; 30(1):85-90. PubMed ID: 2950056
[TBL] [Abstract][Full Text] [Related]
11. The dopamine D2 receptor agonists, quinpirole and bromocriptine produce conditioned place preferences.
Hoffman DC; Dickson PR; Beninger RJ
Prog Neuropsychopharmacol Biol Psychiatry; 1988; 12(2-3):315-22. PubMed ID: 2968613
[TBL] [Abstract][Full Text] [Related]
12. Synergistic effects of D1 and D2 dopamine agonists on turning behaviour in rats.
Robertson GS; Robertson HA
Brain Res; 1986 Oct; 384(2):387-90. PubMed ID: 2946360
[TBL] [Abstract][Full Text] [Related]
13. Postsynaptic dopamine/adenosine interaction: I. Adenosine analogues inhibit dopamine D2-mediated behaviour in short-term reserpinized mice.
Ferré S; Herrera-Marschitz M; Grabowska-Andén M; Ungerstedt U; Casas M; Andén NE
Eur J Pharmacol; 1991 Jan; 192(1):25-30. PubMed ID: 1828236
[TBL] [Abstract][Full Text] [Related]
14. MK-801 (dizocilpine): synergist and conditioned stimulus in bromocriptine-induced psychomotor sensitization.
Wise RA; Mendrek A; Carlezon WA
Synapse; 1996 Apr; 22(4):362-8. PubMed ID: 8867030
[TBL] [Abstract][Full Text] [Related]
15. Dopamine D1- and D2-receptor interaction in turning behaviour induced by dopamine agonists in 6-hydroxydopamine-lesioned rats.
Karlsson G; Jaton AL; Vigouret JM
Neurosci Lett; 1988 May; 88(1):69-74. PubMed ID: 2969468
[TBL] [Abstract][Full Text] [Related]
16. Dopaminergic mechanisms mediating the long-term expression of locomotor sensitization following pre-exposure to morphine or amphetamine.
Vanderschuren LJ; Schoffelmeer AN; Mulder AH; De Vries TJ
Psychopharmacology (Berl); 1999 Apr; 143(3):244-53. PubMed ID: 10353426
[TBL] [Abstract][Full Text] [Related]
17. Effects of selective dopamine D1- and D2-type receptor antagonists on the development of behavioral sensitization to 7-OH-DPAT.
Mattingly BA; Himmler C; Bonta T; Rice LL
Psychopharmacology (Berl); 1998 Dec; 140(4):387-97. PubMed ID: 9888612
[TBL] [Abstract][Full Text] [Related]
18. Reductions in binding and functions of D2 dopamine receptors in the rat ventral striatum during amphetamine sensitization.
Chen JC; Su HJ; Huang LI; Hsieh MM
Life Sci; 1999; 64(5):343-54. PubMed ID: 10072194
[TBL] [Abstract][Full Text] [Related]
19. Morphine and amphetamine sensitization in rats demonstrated under moderate- and high-dose NMDA receptor blockade with MK-801 (dizocilpine).
Ranaldi R; Munn E; Neklesa T; Wise RA
Psychopharmacology (Berl); 2000 Aug; 151(2-3):192-201. PubMed ID: 10972465
[TBL] [Abstract][Full Text] [Related]
20. Sensorimotor gating effects produced by repeated dopamine agonists in a paradigm favoring environmental conditioning.
Feifel D; Priebe K; Johnstone-Miller E; Morgan CJ
Psychopharmacology (Berl); 2002 Jul; 162(2):138-46. PubMed ID: 12110991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
